| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-977 | |
| Phytochemical name or plant extracts | Lyratol C | |
| PMID | 28123569 | |
| Literature evidence | Additionally, the present study provides evidence in support of the hypothesis that S. lyratum may be a promising candidate for the development of novel cancer therapies. | |
| IUPAC name | (1R,2R,4aR,6S,8aS)-6-(1,2-dihydroxypropan-2-yl)-8a-methyl-4-methylidene-1,2,3,4a,5,6,7,8-octahydronaphthalene-1,2-diol | |
| Phytochemicals’ class or type of plant extracts | Sesquiterpenoid | |
| Source of phytochemicals or plant Extracts | Solanum lyratum | |
| Geographical availability | Cambodia, China North-Central, China South-Central, China Southeast, Hainan, Japan, Korea, Taiwan, Tibet, Vietnam | |
| Plant parts | Whole plant | |
| Other cancers | Breast cancer, Lung cancer, Stomach cancer, hepatocarcinoma | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | 35.8±2.1 µg/ml against MCF-7 | |
| Potency | NA | |
| Cell line/ mice model | MCF-7, HCT-8, A-549, SGC-7901 and BEL-7402 | |
| Additional information | Additionally, the present study provides evidence in support of the hypothesis that S. lyratum may be a promising candidate for the development of novel cancer therapies. | |
| PubChem ID | 42604342 | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:927300-1 | |
| Safety | NA |